Jain R K
Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114, USA.
Annu Rev Biomed Eng. 1999;1:241-63. doi: 10.1146/annurev.bioeng.1.1.241.
Extraordinary advances in molecular biology and biotechnology have led to the development of a vast number of therapeutic anti-cancer agents. To reach cancer cells in a tumor, a blood-borne therapeutic molecule, particle, or cell must make its way into the blood vessels of the tumor and across the vessel wall into the interstitium, which it then must migrate through. Unfortunately, tumors often develop in ways that hinder these steps. The goal of research in this area is to analyze each of these steps experimentally and theoretically and integrate the resulting information into a unified theoretical framework. This paradigm of analysis and synthesis has fostered a better understanding of physiological barriers in solid tumors and aided in the development of novel strategies to exploit and/or overcome these barriers for improved cancer detection and treatment.
分子生物学和生物技术的非凡进展已促成了大量治疗性抗癌药物的研发。为了抵达肿瘤中的癌细胞,一种通过血液传播的治疗性分子、颗粒或细胞必须进入肿瘤的血管,并穿过血管壁进入间质,然后在间质中迁移。不幸的是,肿瘤常常以阻碍这些步骤的方式发展。该领域的研究目标是通过实验和理论分析这些步骤中的每一步,并将所得信息整合到一个统一的理论框架中。这种分析与综合的模式促进了对实体瘤中生理屏障的更好理解,并有助于开发新策略来利用和/或克服这些屏障,以改善癌症检测和治疗。